JAK2 and nasopharyngeal carcinoma: In this study, we demonstrated that DDAH1 interacts with EGFR, promoting EGFR dimerization and autophosphorylation, thereby activating the downstream JAK2‐STAT3 signaling pathway and ultimately inducing cisplatin resistance in NPC cells.